R, K.S., Entschladen. F. Norepinephrine promotes the 1integrin-mediated adhesion of MDA-MB-231 cells to vascular endothelium by the induction of a GRO release. Mol Cancer Res. 2012; 10: 197-207.two.three.four.5.www.impactjournals/oncotargetOncotargetthe Endothelium. Cancer Res. 2001; 61: 4851-4857. 18. Khaldoyanidi, S.K., Glinsky, V.V., Sikora, L., Glinskii, A.B., Mossine, V.V., Quinn, T.P., Glinsky, G.V., Sriramarao, P. MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion below flow circumstances is mediated in component by Thomsen-Friedenreich antigengalectin-3 interactions. J Biol Chem. 2003; 278: 4127-4134. 19. Heimburg, J., Yan, J. Morey, S., Wild, L., Glinskii, O.V., Huxley, V.H., Klick, R., Roy, R., Glinsky, V.V., Rittenhouse-Olson, K. Inhibition of Spontaneous Breast Cancer Metastasis by Anti-Thomsen-Friedenreich Antigen Monoclonal Antibody JAA-F11. Neoplasia. 2006; 8: 939948. 20. Glinskii, O.V., Sud, S., Mossine, V.V., Mawhinney, T.P., Anthony, D.C., Glinsky, G.V., Pienta, K.J., Glinsky, V.V. Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-LLeucine. Neoplasia. 2012; 14: 65-73. 21. Raz, A., Lotan, R. (1987) Endogenous galactoside-binding lectins: a brand new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev. 1987; six: 433-452. 22. Inohara, H., Raz, A. (1994) Effects of all-natural complex carbohydrate (citrus pectin) on murine melanoma cell properties associated to galectin-3 functions. Glycoconj J. 1994; 11: 527-532. 23. Lotan, R., Raz, A. Endogenous lectins as mediators of tumor cell adhesion. J Cell Biochem. 1988; 37: 107-117. 24. Nakahara, S., Oka, N., Raz, A. Around the part of galectin-3 in cancer apoptosis. Apoptosis. 2005; ten: 267-275. 25. Glinsky, V.V., Kiriakova, G., Glinskii, O.V., Mossine, V.V., Mawhinney, T.P., Turk, J.R., Glinskii, A.B., Huxley, V.H., Value, J.E., Glinsky, G.V. Synthetic Galectin-3 Inhibitor Increases Metastatic Cancer Cell Sensitivity to Taxol-Induced Apoptosis In Vitro and In Vivo. Neoplasia. 2009; 11: 901-909. 26. Balan V, Wang Y, Nangia-Makker P, Kho D, Bajaj M, Smith D, Heilbrun L, Raz A, Heath E. Galectin-3: a feasible complementary marker for the PSA blood test. Oncotarget. 2013; four: 542-549. 27. Glinskii, O.V., Turk, J.R., Pienta, K.J., Huxley, V.H., and Glinsky, V.V. Evidence of Porcine and Human Endothelium Activation by Cancer-Associated Carbohydrates Expressed on Glycoproteins and Tumor Cells. J Physiol. 2004; 554: 89-99. 28. Fukushi, J., Makagiansar, I.T., Stallcup W.B: NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol Biol Cell. 2004; 15: 3580-3590. 29. Takada, Y., Wayner, E.A., Carter, W.G., Hemler, M.E. (1988) Extracellular matrix receptors, ECMRII and ECMRI, for collagen and fibronectin correspond to VLA2 and VLA-3 inside the VLA family members of heterodimers.Sarolaner J Cell Biochem.C 87 1988; 37: 385-393.PMID:23912708 www.impactjournals/oncotarget30. Munshi, H.G., Wu, Y.I., Mukhopadhyay, S., Ottaviano, A.J., Sassano, A., Koblinski, J.E., Platanias, L.C., Stack, M.S. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPKmodulated tissue inhibitor of metalloproteinases two expression controls transforming growth factor-beta1induced pericellular collagenolysis. J Biol Chem. 2004; 279: 39042-39050. 31. Guha, P., Kaptan, E., Bandyopadhyaya, G., Kaczanowska, S., Davila, E., Thompson, K., Martin, S.S., Kalvakolanu, D.V.,.